Analysis and Evaluation on the Medication Status of 7401 Outpatient Prescriptions for Ginkgo Biloba Dropping Pills
Objective:This study aims to analyze the application of Ginkgo biloba dropping pills in a hospital,evaluate the level of clinical rational drug use,and provide a reference for improving the quality of clinical drug use.Methods:The study collected and analyzed the usage of Ginkgo biloba dropping pills in outpatient prescriptions from January 2019 to December 2022 using the hospital information system,resulting in a total of 7401 prescriptions.The collected prescriptions were sorted and analyzed to evaluate the rationality of drug use,including departmental distribution,indications for use,and concomitant drug use.Results:A total of 7401 prescriptions of Ginkgo biloba dropping pills involved 23 outpatient departments.The ENT department had the highest usage rate(76.68%),followed by vertigo(8.27%),neurology(5.04%),and convenience clinic(3.12%).A total of 256 diseases were involved,with otorhinolaryngology having the highest incidence rate(75.20%),followed by neurological diseases(16.84%)and cardiovascular diseases(5.52%).Only 250 prescriptions were for single use.The remaining 7151 prescriptions were for concomitant use.Among the top ten concomitant drugs,choline alfoscerate capsules,mecobalamin tablets,and Wuling capsules.The qualified rate of Ginkgo biloba dropping pills was 98.84%.Conclusion:The use of Ginkgo biloba dropping pills in this hospital is generally reasonable,but there are cases of overmedication and incomplete clinical diagnosis written by Western medicine physicians.Hospitals should strengthen the management of prescriptions.
Ginkgo biloba dropping pillsoutpatient prescriptiondrug analysisoff-label drug userational drug use
万方数据
维普
